Medicare Enrolled
Dr. Stephen Werth, M.D.
Dermatology · Quincy, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Werth from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Werth?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Werth
Dr. Stephen Werth is a dermatology specialist in Quincy, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Werth performed 5,498 Medicare services across 3,790 unique beneficiaries.
Between the years covered by Open Payments, Dr. Werth received a total of $2,568 from 28 pharmaceutical and/or device companies across 103 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Werth is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 13% volume in MA
$2,568 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,498
Medicare services
Top 13% in MA for dermatology
3,790
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~275 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,798 | $67 | $303 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,408 | $6 | $24 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
603 | $46 | $233 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
446 | $85 | $359 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
259 | $46 | $177 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
123 | $97 | $402 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
122 | $79 | $374 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
101 | $256 | $1,061 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
101 | $95 | $427 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
72 | $119 | $622 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
68 | $110 | $848 |
| Surgical removal of facial skin cancer, 1.1-2.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the removed tissue is between 1.1 and 2.0 centimeters. |
67 | $121 | $928 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | 56 | $284 | $1,101 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
40 | $45 | $191 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
33 | $130 | $963 |
| Intermediate wound repair, 2.6-7.5 cm This procedure involves stitching a wound on the neck, hands, feet, or genitals that measures between 2.6 and 7.5 centimeters. It is classified as an intermediate repair requiring layered closure. |
26 | $277 | $1,081 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
26 | $144 | $591 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring 1.1 to 2.0 centimeters from the scalp, neck, hands, feet, or genitals. |
24 | $115 | $878 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
23 | $43 | $198 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
21 | $69 | $338 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters. |
16 | $76 | $516 |
| Chemotherapy administration, 1-7 injections This procedure involves the administration of chemotherapy medication through one to seven separate injections. |
16 | $61 | $296 |
| Intermediate wound repair, face or mouth, 2.5 cm or less A medical procedure to close a wound on the face, ears, eyelids, nose, lips, or mouth that is 2.5 centimeters or smaller. This type of repair involves more than simple closure but is less complex than a major repair. |
15 | $252 | $993 |
| Destruction of cancerous skin growth on face, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 0.6 and 1.0 centimeters in diameter. |
12 | $122 | $623 |
| Intermediate wound repair, 7.6-12.5 cm This procedure involves stitching a wound on the scalp, underarms, trunk, arms, or legs that measures between 7.6 and 12.5 centimeters. It includes cleaning the wound and closing it with sutures to promote healing. |
11 | $305 | $1,163 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 11 | $123 | $655 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$2,568
Total received (2018-2024)
Avg $367/year across 7 years
Top 35% in MA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
103
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,265 (88.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$303 (11.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$414
2023
$470
2022
$534
2021
$299
2020
$231
2019
$292
2018
$327
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$79
PFIZER INC.
$58
GENZYME CORPORATION
$49
Dermavant Sciences, Inc.
$44
Sandoz Inc.
$42
Arcutis Biotherapeutics, Inc.
$40
LEO Pharma Inc.
$30
SUN PHARMACEUTICAL INDUSTRIES INC.
$26
Regeneron Healthcare Solutions, Inc.
$25
E.R. Squibb & Sons, L.L.C.
$22
Top 3 companies account for 44.9% of 2024 payments
All-time payments by company (2018-2024) ›
LEO Pharma Inc.
$276
Janssen Biotech, Inc.
$242
Lilly USA, LLC
$182
Genentech USA, Inc.
$175
ABBVIE INC.
$170
AbbVie Inc.
$165
Incyte Corporation
$147
PFIZER INC.
$143
Novartis Pharmaceuticals Corporation
$117
Sun Pharmaceutical Industries Inc.
$116
GENZYME CORPORATION
$105
AbbVie, Inc.
$83
Sandoz Inc.
$76
E.R. Squibb & Sons, L.L.C.
$71
Dermavant Sciences, Inc.
$60
UCB, Inc.
$56
SUN PHARMACEUTICAL INDUSTRIES INC.
$50
Galderma Laboratories, L.P.
$49
Regeneron Healthcare Solutions, Inc.
$46
Merz North America, Inc.
$42
Arcutis Biotherapeutics, Inc.
$40
DERMIRA, INC.
$27
Boehringer Ingelheim Pharmaceuticals, Inc.
$26
Amgen Inc.
$23
Mission Pharmacal Company
$23
MERZ NORTH AMERICA, INC.
$23
Mayne Pharma Inc.
$19
Celgene Corporation
$17
Top 3 companies account for 27.3% of all-time payments
Associated products mentioned in payments ›
ADBRY · Avar · Bimzelx · COSENTYX · Cimzia · DORYX · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EUCRISA · Enbrel · Erivedge · HYRIMOZ · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · LIBTAYO · OPZELURA · ORACEA · Otezla · REMICADE · RINVOQ · SKYRIZI · SPEVIGO · Sotyktu · TALTZ · TREMFYA · Tremfya · VTAMA · Winlevi · XELJANZ · XEOMIN · Xeomin · Xolair · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Dermatologists within 10 mi
399
Per 100K population
55.1
County median income
$126,497
Nearest hospital
BETH ISRAEL DEACONESS HOSPITAL - MILTON
3.4 mi
3.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Werth is a clinical cardiology specialist, with above-average Medicare volume (top 13% in MA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Werth experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Werth performed 1,798 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Werth receive payments from pharmaceutical companies?
Yes. Dr. Werth received a total of $2,568 from 28 companies across 103 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Werth's costs compare to other dermatologists in Quincy?
Dr. Werth's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Werth) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Quincy
Browse dermatologists in Quincy ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in MA
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in MA
Which MA dermatologists receive the most from drug and device companies.
By company
LEO Pharma Inc. Payments to Doctors
See all physicians who received payments from LEO Pharma Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology